Tafenoquine Succinate
Tafenoquine Succinate (WR 238605) is an 8-aminoquinoline compound used for malaria prophylaxis. It is widely employed in research to study its antiplasmodial mechanisms and efficacy in both in vitro assays and in vivo animal models of malaria infection.
Product Specifications
CAS Number
106635-81-8
Product Name Alternative
WR238605, WR-238605, WR 238605, WR 238605 (Succinate), Tafenoquine, Tafenoquine Succinate, antimalarial, Anti-malarial, inhibit, Parasite, Inhibitor
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
99.77% (May vary between batches)
Solubility
DMSO:135 mg/mL (232.13 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (6.88 mM)
Smiles
OC (=O) CCC (O) =O.COc1cc (C) c2c (Oc3cccc (c3) C (F) (F) F) c (OC) cc (NC (C) CCCN) c2n1
Molecular Formula
C28H34F3N3O7
Molecular Weight
581.58
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Dehydroepiandrosterone sulfate, DHEA-S ELISA Kit
Human Dehydroepiandrosterone sulfate, DHEA-S ELISA Kit
CD41, CD61 (CD41b, GP2B, GP-IIb, GPIIb, GP3A, GP-IIIa, GPIIIa, GTA, HPA3, Integrin alpha 2b, ITGA2B, Integrin beta 3, ITGB3, Platelet Glycoprotein IIb of IIb/IIIa Complex) (MaxLight 490)
Anti-GNAI2 Rabbit Monoclonal Antibody, Carrier-free
